Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S WOOD

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Biochemical and Biophysical Research Communications|July 16, 1990
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxideK S Wood, G M Buga, R E Byrns, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1986
Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not veinL J Ignarro, K S Wood, R G Harbison, et al.
The American Journal of Physiology|November 1, 1987
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIPL J Ignarro, R E Byrns, G M Buga, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1986
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acidL J Ignarro, R G Harbison, K S Wood, et al.
Circulation Research|December 1, 1987
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radicalL J Ignarro, R E Byrns, G M Buga, et al.
Bone & Joint Research|September 5, 2015
Predicting early clinical function after hip or knee arthroplastyS Poitras, K S Wood, J Savard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxationL J Ignarro, R E Byrns, G M Buga, et al.
European Journal of Pharmacology|February 14, 1989
Endothelium-derived nitric oxide relaxes nonvascular smooth muscleG M Buga, M E Gold, K S Wood, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscleL J Ignarro, G M Buga, R E Byrns, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and veinM E Gold, K S Wood, R E Byrns, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|July 16, 1990
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxideK S Wood, G M Buga, R E Byrns, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1986
Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not veinL J Ignarro, K S Wood, R G Harbison, et al.
The American Journal of Physiology|November 1, 1987
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIPL J Ignarro, R E Byrns, G M Buga, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1986
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acidL J Ignarro, R G Harbison, K S Wood, et al.
Circulation Research|December 1, 1987
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radicalL J Ignarro, R E Byrns, G M Buga, et al.
Bone & Joint Research|September 5, 2015
Predicting early clinical function after hip or knee arthroplastyS Poitras, K S Wood, J Savard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxationL J Ignarro, R E Byrns, G M Buga, et al.
European Journal of Pharmacology|February 14, 1989
Endothelium-derived nitric oxide relaxes nonvascular smooth muscleG M Buga, M E Gold, K S Wood, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1988
Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscleL J Ignarro, G M Buga, R E Byrns, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and veinM E Gold, K S Wood, R E Byrns, et al.
Pageof 6